The trace view, one year on
We shipped the trace view expecting associates to check every step. They open it in one query in five, and almost always for the same reason. What we expected, what happened and what we changed.
We shipped the trace view expecting associates to check every step. They open it in one query in five, and almost always for the same reason. What we expected, what happened and what we changed.
What should a voice agent do when the caller starts crying? We spent six months with three clinicians and 140 mock intakes finding out. The answers were mostly about pacing and consent.
Across 184 anonymised acquisition agreements with European biotech targets, what milestone types, efforts standards and dispute mechanisms look like, and what Review does with that.
A dismissed flag costs a reviewer forty-one seconds. That is the small number. The larger one is what happens to the next three flags.
Our in-house model: what it was trained on, what it was not, how it was evaluated against the models we previously routed to, and where it still falls short.
Simulation models venues, not named arbitrators. This note sets out what a corpus of published awards actually supports, where selection bias defeats it, and why we stopped short.
What 480 anonymised 2024 technology SPAs in our index say about material adverse change drafting: carve-out counts, cyber language, and the slow exit of the pandemic clause.
Accept rate rewards timid redlines. Here is the four-part measure we use instead, the sample behind it, and the places where it still misleads us.
A bilingual contract that differs between its two language versions is a dispute waiting for a tribunal. Here is how we test for parity, what the test catches, and what it still misses.
Time saved is the easiest number to inflate. Here is how we define first-pass review time, who we measure, what we exclude and where the measurement still misleads.